AMENDMENT NO. 1 TO LICENSE AGREEMENT

Exhibit 10.28

AMENDMENT NO. 1 TO LICENSE AGREEMENT

This Amendment (“Amendment”) is a modification of the License Agreement by and between University of Basel, having its principal offices located at Xxxxxxxxxxxx 00, 0000 Xxxxx, Xxxxxxxxxxx (“UNIBAS”) and Hookipa Biotech GmbH, having its principal offices located at Xxxxxx-Xxxxxxxxxx-Xxxxx 0, 0000 Xxxxxx, Xxxxxxx (“Hookipa”), made effective on October 15, 2020 ("Agreement").

This Amendment is made according to Article 10.6 of the Agreement. This Amendment is to be construed consistently insofar as possible with the Agreement, but in the event of a conflict, this Amendment shall control. Any capitalized terms used herein shall have the same meaning as set forth for such terms in the Agreement.

The Parties hereby agree as follows:

Article 3.2(c) shall be deleted in its entirety and replaced with the following:

LICENSEE shall have the right to request one postponement of any one of the two milestones of Article 3.2(a)(ii) and (iii) above (i.e. only one under this paragraph) by eight (8) months against payment of a rescheduling fee of one hundred thousand Swiss Francs (CHF 100’000). If such milestone is so extended or postponed, the subsequent milestones are automatically extended or postponed by the same amount of time without additional fees.

All other terms and conditions of the Agreement remain unchanged and in full force.

This Amendment shall be effective on 11 July 2022.

IN WITNESS WHEREOF, the Parties hereby have executed this Amendment the day and year herein written.

Hookipa Biotech GmbH				University of Basel


By:				By:
Name: Xxxxxxxx Xxxxxxx				Name:
Title: CFO				Title:


Date:				Date:


				University of Basel


				By:
				Name:
				Title:

				Date:

Document Metadata

Table of Contents

AMENDMENT NO. 1 TO LICENSE AGREEMENT

Document Metadata